Tevogen Bio faces hurdles with unclear COVID-19 therapy demand, ambitious projections, and risks ahead. Click here to read an ...

Explore the impact of Stellantis's disputes with unions, weakened financial performance, and a 9% drop in vehicle sales.

Wells Fargo & Company ( NYSE: WFC) Q1 2025 Earnings Conference Call April 11, 2025 10:00 AM ET John Campbell - Director, Investor Relations Charlie Scharf - Chief Executive Officer Mike Santomassimo - ...

Dr. Maguire is an ardent, experienced value investor. Most of his career has been spent as a healthcare executive and business owner, caring for patients diagnosed with cancer in coastal North ...

The 200DMA Signal suggests S&P 500 Index losses amidst U.S.-China tensions. Click for my look at technical triggers for the ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

Celestica reports 21% YoY revenue growth in CY 2024, driven by CCS expansion. Click here to find out why CLS stock is a Buy.

NVR faces short-term challenges but thrives on a 3.5M U.S. housing shortage. With a 25% upside, discover why it's a long-term ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

Soaring rates, a falling dollar, and tariff-driven foreign outflows impact U.S. markets, bond yields, and stock valuations.

CoreWeave, Inc. IPO offers a compelling near-term trade despite structural flaws. Read more on CRWV stock prospects and why ...

Milk gains from Chinese demand and internal improvements, including a turnaround at a struggling unit. Find out why ACOPY ...